INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 05, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 19,853 | -- | -- |
| Jan 05, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 20,000 | -- | -- |
| Jan 05, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 13,650 | -- | -- |
| Jan 05, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 5,147 | -- | -- |
| Jan 05, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 4,216 | -- | -- |
| Jan 05, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 44,853 | -- | -- |
| Jan 05, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 30,000 | -- | -- |
| Jan 05, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 25,784 | -- | -- |
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 5,149 | -- | -- |
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 4,800 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.